GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Accumulated other comprehensive income (loss)

Syntara (ASX:SNT) Accumulated other comprehensive income (loss) : A$24.73 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Syntara Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Syntara's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was A$24.73 Mil.

Syntara's quarterly Accumulated other comprehensive income (loss) increased from Dec. 2022 (A$23.91 Mil) to Jun. 2023 (A$24.31 Mil) and increased from Jun. 2023 (A$24.31 Mil) to Dec. 2023 (A$24.73 Mil).

Syntara's annual Accumulated other comprehensive income (loss) increased from Jun. 2021 (A$22.64 Mil) to Jun. 2022 (A$23.46 Mil) and increased from Jun. 2022 (A$23.46 Mil) to Jun. 2023 (A$24.31 Mil).

Syntara Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Syntara's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara Accumulated other comprehensive income (loss) Chart

Syntara Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.32 22.64 23.46 24.31 24.95

Syntara Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.46 23.91 24.31 24.73 24.95

Syntara Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Syntara Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Syntara's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Syntara Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ASX:VIT ASX:IDT ASX:MVP ASX:LGP ASX:ECS ASX:NXS ASX:CAN ASX:RGT ASX:IVX ASX:LV1 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XTAE:TEVA XSWX:SDZ NBIX NSE:DIVISLAB
Traded in Other Exchanges
UUDA:Germany
Address
20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Website
https://www.syntaratx.com.au
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.